Sickbay.com

About Sickbay.com

Medical Informatics Corp. (MIC), the company behind Sickbay.com, operates as a software-based monitoring and analytics firm targeting the healthcare industry. Founded in 2010 by Emma Fauss and Craig Rusin, the Houston-based company aims to unify patient monitoring workflows. Fauss, the CEO, holds a Ph.D. in electrical and computer engineering and an MBA with a healthcare concentration, while Rusin's background is in chemical engineering with a focus on nonlinear dynamics, which formed the basis for the platform's grid-computing technology. Their collaboration began in graduate school, driven by a shared interest in solving complex data challenges in healthcare.

The company's core offering is the Sickbay™ platform, an FDA-cleared, vendor-neutral clinical surveillance and analytics solution. It addresses the critical issue of data silos in hospitals by aggregating, archiving, and transforming high-resolution, time-series data from disparate biomedical devices, such as cardiac monitors and ventilators, in near real-time. This unified data, which includes waveforms often discarded by legacy systems, is integrated with electronic health record (EHR) information like lab results and medications. The platform makes this comprehensive patient data accessible to care teams, researchers, and algorithm developers through a web-based interface on any device, enabling remote monitoring, virtual ICUs, and centralized command centers.

MIC's business model is centered on providing this platform to hospitals and health systems, which helps them streamline IT infrastructure, reduce costs associated with multiple vendors, and improve operational efficiencies. By offering a single point of integration, Sickbay allows healthcare providers to enhance patient monitoring, improve staffing ratios, and accelerate research. The platform also serves as a foundation for developing and deploying machine learning and AI-driven predictive analytics, allowing hospitals to create their own patient-specific risk calculators and protocol monitors. The company has secured significant funding, including a Series B round, from investors such as Intel Capital, DCVC, and Catalio Capital Management, to fuel its growth and expand its team.